[Translation] A randomized, double-blind, placebo-controlled, dose-escalation Phase Ia clinical trial to evaluate the safety, tolerability, pharmacokinetics, and immunogenicity of EP-9001A injection in healthy subjects.
主要目的:评价EP-9001A注射液在健康受试者中的安全性和耐受性。
次要目的:1) 评价EP-9001A注射液在健康受试者中的药代动力学特征;2) 评价EP-9001A注射液在健康受试者中的免疫原性。
[Translation] Primary objective: To evaluate the safety and tolerability of EP-9001A injection in healthy subjects.
Secondary objectives: 1) To evaluate the pharmacokinetic characteristics of EP-9001A injection in healthy subjects; 2) To evaluate the immunogenicity of EP-9001A injection in healthy subjects.